- Analysts raised the price target on Emerson Electric Co EMR post Q1 results.
- Morgan Stanley analyst Joshua Pokrzywinski raised Emerson Electric Co's EMR price target to $108 (an upside of 11.3%) from $102 and maintained an Equal-Weight rating on the shares.
- Credit Suisse analyst John Walsh raised the price target to $112 (an upside of 15.4%) from $111 and kept an Outperform rating on the shares.
- Related: Emerson Electric Reports 8% Sales Growth In Q1; Raises FY22 Guidance.
- Citi analyst Andrew Kaplowitz raised the price target to $123 from $120 and maintained a Buy rating on the shares.
- Kaplowitz mentions the company's "strong" Q1 earnings and a raised fiscal 2022 outlook is supported by recent order momentum and highlights Emerson's solid positioning for sustained earnings growth runway in a recovering global economic environment.
- Price Action: EMR shares are trading lower by 0.45% at $97.13 on the last check Thursday.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in